2-nitro-N,N-dipropyl-aniline | 13475-68-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-nitro-N,N-dipropyl-aniline
• 英文别名: 2-Nitro-N,N-dipropyl-anilin；2-Di-n-propylamino-1-nitro-benzol；2-Nitro-N,N-dipropyl-anilin；nitro-N,N-dipropyl-aniline；2-nitro-N,N-dipropylaniline
• CAS: 13475-68-8
• 化学式: C₁₂H₁₈N₂O₂
• mdl: MFCD25958214
• 分子量: 222.287
• InChiKey: FSJPCUFEJMQFEP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  49.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-nitro-N,N-dipropyl-aniline 在 bis(1,5-cyclooctadiene)diiridium(I) dichloride 、 palladium 10% on activated carbon 、 氢气 作用下， 以 甲醇 、 2,2,2-三氟乙醇 为溶剂， 20.0~80.0 ℃ 、405.33 kPa 条件下， 反应 72.0h， 生成 (9ci)-2-乙基-1-丙基-1H-苯并咪唑
  参考文献：
  名称：

  Synthesis of benzimidazoles via iridium-catalyzed acceptorless dehydrogenative coupling

  摘要：

  苯并咪唑类化合物通过铱催化的受体无氧脱氢偶联反应，产率较高地合成。

  DOI：

  10.1039/c5ob00904a
• 作为产物：
  描述：

  丙醛 、 2-硝基苯胺 在 sodium tetrahydroborate 、 硫酸 作用下， 以 四氢呋喃 为溶剂， 反应 1.67h， 以16%的产率得到2-nitro-N,N-dipropyl-aniline
  参考文献：
  名称：

  New Experiments in the Reductive N-Alkylation and N-Peralkylation of Aromatic Amines

  摘要：

  Some secondary and primary aromatic amines were variously N-alkylated and N-peralkylated by the aldehyde-sodium borohydride procedure in acidic aqueous solution. The procedure lends itself to the alpha-mono and alpha,alpha'-dideuterium labelling of the new N-substituent(s).

  DOI：

  10.1080/00397919408012638

文献信息

• Indolyl-3-glyoxylic acid derivatives having antitumor action
  申请人：Nickel Bernd

  公开号：US20080027110A1

  公开（公告）日：2008-01-31

  The invention relates to the use of N-substituted indole-3-glyoxylamides of the general formula I as antitumor agents and to a pharmaceutical composition having antitumor action, characterized in that it contains at least one of the compounds of the general formula 1, if appropriate also in the form of the physiologically tolerable acid addition salts or N-oxides. Furthermore, the invention also includes antitumor agents comprising as active compound one or more N-substituted indole-3-glyoxylamides according to the general formula 1 and, if appropriate, their physiologically tolerable acid addition salts and, if possible, N-oxides and a pharmaceutically utilizable carrier and/or diluent or auxiliary substance in the form of tablets, coated tablets, capsules, solutions for infusion or ampoules, suppositories, patches, powder preparations which can be employed by inhalation, suspensions, creams and ointments.

  本发明涉及使用一般式I的N-取代吲哚-3-甘氧酰胺作为抗肿瘤剂，以及具有抗肿瘤作用的药物组合物，其特征在于至少含有一种一般式1的化合物，如适当，还可以是生理耐受的酸加成盐或N-氧化物的形式。此外，本发明还包括作为活性化合物的一种或多种N-取代吲哚-3-甘氧酰胺的抗肿瘤剂，以及它们的生理耐受的酸加成盐和可能的N-氧化物，以及在片剂、包衣片剂、胶囊、输注溶液或安瓿、栓剂、贴片、可通过吸入使用的粉剂制剂、悬浮液、乳霜和软膏等药物可利用载体和/或稀释剂或辅助物质的形式。
• Potent 2′-aminoanilide inhibitors of cFMS as potential anti-inflammatory agents
  作者：Raymond J. Patch、Benjamin M. Brandt、Davoud Asgari、Nand Baindur、Naresh K. Chadha、Taxiarchis Georgiadis、Wing S. Cheung、Ioanna P. Petrounia、Robert R. Donatelli、Margery A. Chaikin、Mark R. Player

  DOI：10.1016/j.bmcl.2007.09.057

  日期：2007.11

  A series of 2 '-aminoanilides have been identified which exhibit potent and selective inhibitory activity against the cFMS tyrosine kinase. Initial SAR studies within this series are described which examine aroyl and amino group substitutions, as well as the introduction of hydrophilic substituents on the benzene core. Compound 47 inhibits the isolated enzyme (IC50 = 0.027 mu M) and blocks CSF-1-induced proliferation of bone marrow-derived macrophages (IC50 = 0.11 mu M) and as such, serves as a lead candidate for further optimization studies. (C) 2007 Elsevier Ltd. All rights reserved.
• Weissenberger, Monatshefte fur Chemie, 1912, vol. 33, p. 826
  作者：Weissenberger

  DOI：——

  日期：——
• US4097524A
  申请人：——

  公开号：US4097524A

  公开（公告）日：1978-06-27
• Synthesis of benzimidazoles via iridium-catalyzed acceptorless dehydrogenative coupling
  作者：Xiang Sun、Xiao-Hui Lv、Lin-Miao Ye、Yu Hu、Yan-Yan Chen、Xue-Jing Zhang、Ming Yan

  DOI：10.1039/c5ob00904a

  日期：——

  Benzimidazoles were prepared in good yieldsviathe iridium-catalyzed acceptorless dehydrogenative coupling of tertiary amines and arylamines.

  苯并咪唑类化合物通过铱催化的受体无氧脱氢偶联反应，产率较高。